About this trial

The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease or REM Sleep Behavior Disorder (RBD). The main question it aims to answer is:

Can doctors find a protein called alpha-synuclein in colon tissue samples from people with Parkinson's disease and RBD?

Currently, Parkinson's disease is diagnosed by observing symptoms like tremors and movement problems and RBD by loss of muscle atonia during REM sleep, but by then the disease has already progressed significantly. Earlier detection could help doctors start treatment sooner.

Eligibility criteria

Qualifiers

Relatively healthy men and women ≥40-99 years of age

Patients with a diagnosis of

Clinically confirmed PD or

Clinically confirmed RBD with no diagnosis of PD, DLB or MSA

Disqualifiers

Use of anticoagulants (Plavix or aspirin alone is allowed)

Under active treatment for colon cancer; 30-day post anti-cancer treatment allowed

Current, ongoing gastrointestinal illness

Recent intrabdominal surgery

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

40 Participants
are grouped into 2 trial groups

Locations

1
Digestive Disease Associates06405, BranfordConnecticut, United States

Sponsors and collaborators

CND Life Sciences

Lead sponsor